Startup based in the United States, most recent round Acquired.
Based in the United States, Arthrosi is a startup. Arthrosi has been acquired.
Arthrosi is a clinical-stage biotech company developing AR882, a novel therapy targeting gout and chronic kidney disease with demonstrated sustained urate lowering and potential to treat gout patients with renal impairment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.